Central PA Hematology-Medical Oncology Associates PC — Lemoyne, Pennsylvania

Central PA Hematology-Medical Oncology Associates PC is a clinical research site located in Lemoyne, Pennsylvania, United States 17043.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Central PA Hematology-Medical Oncology Associates PC has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer.

Sponsors: National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lemoyne

Browse all research sites in Pennsylvania · View every site in Lemoyne

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central PA Hematology-Medical Oncology Associates PC?

Central PA Hematology-Medical Oncology Associates PC has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central PA Hematology-Medical Oncology Associates PC conducted?

Central PA Hematology-Medical Oncology Associates PC has 7 clinical trials on record, with 2 currently active. Their work covers Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer.

Is Central PA Hematology-Medical Oncology Associates PC accredited by Crixeo Clinical Trials?

Central PA Hematology-Medical Oncology Associates PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central PA Hematology-Medical Oncology Associates PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.